U.S. Research Labs to Phase Out Animal Testing Following Landmark Shift

Washington – After decades of advocacy, the United States is poised to significantly reduce its reliance on Animaltesting in research, driven by a coordinated effort across key federal agencies. The National Institutes of Health (NIH), the Food and Drug Administration (FDA), and the Environmental Protection Agency (EPA) have announced they will encourage the adoption of human-based technologies, including lab-grown cells and organoid models, as alternatives to Animal studies.

Breakthrough in Endometriosis Research Offers New Hope

MIT bioengineer Linda Griffith pioneered a novel approach to studying endometriosis, a painful condition affecting one in ten women. Instead of using animals, she cultivated tiny replicas of uterine tissue – “organoids” – from patient cells on lab chips, allowing for precise analysis and testing of potential treatments. Previously, a promising drug discovered in mice failed in human trials, highlighting the limitations of Animal models.

Shift Away From Animal Testing Gains Momentum

The shift follows the passage of the 1938 Federal Food, Drug and Cosmetic Act, which initially relied heavily on Animal testing. However, safer and more effective methods have emerged, particularly in the cosmetics industry, yet millions of animals continue to endure invasive testing and often fatal experiments. Despite legal requirements for some companies, U.S. labs are now moving away from animal testing, spurred by the work of Humane World for Animals and other advocacy groups.

To the Rescue! Gala Supports Animal Welfare

The annual To the Rescue! gala, benefiting Humane World for Animals, will be held on November 6, 2026, at Cipriani 42nd Street in New York City. The organization’s mission is to protect animals and promote kinder alternatives to animal testing.